107 patents
Page 3 of 6
Utility
Quantitative Auxiliary-free Chirality Sensing with a Metal Probe
14 Apr 22
The present invention relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, and providing a probe selected from the group consisting of metal salts.
Christian WOLF, Zeus A. O. DE LOS SANTOS, Ciaran LYNCH
Filed: 11 Sep 19
Utility
Systems and Methods for Identifying and Isolating Invasive Subpopulations of Cancer Cells In Real-time
14 Apr 22
Systems and methods for characterizing cancer cells are disclosed.
Anton Wellstein, Ghada M. Sharif, Makarand Paranjape, Leon Der
Filed: 9 Sep 19
Utility
0r1sfi857jrjmyp17g82intzn3
14 Apr 22
Embodiments of the present systems and methods may provide techniques to predict the success or failure of a drug used for disease treatment.
Ophir Frieder, Hao-Ren Yao, Der-Chen Chang
Filed: 20 Dec 21
Utility
5piemybs2sfq2aiujzssnt y0cmrxivlywk9zu4qfipcec
31 Mar 22
Hemayet ULLAH, Sivanesan DAKSHANAMURTHY
Filed: 29 Oct 19
Utility
no5w0629nk0cxp1c1h699g1qjkc03jijil2kovgo9a
3 Mar 22
Methods of treating with radiation therapy a subject having cancer, in which the method comprises administering radiation therapy to the subject.
Anatoly Dritschilo, Amrita K. Cheema, Scott Grindrod, Xiaogang Zhong
Filed: 15 Sep 21
Utility
dpxk4e3eb2wb103yydrncjgrvs5eh6bqu2y2qumr5
6 Jan 22
Provided herein are methods for treating nonalcoholic steatohepatitis (NASH) in a subject, comprising administering to a subject having NASH an effective amount of a CCK receptor inhibitor.
Jill P. SMITH
Filed: 5 Nov 19
Utility
fuubbzt p67uodu6n3b7g
6 Jan 22
The present application is directed to methods and compositions for treating a condition marked by enhanced inflammation in the central nervous system (CNS).
Jeffrey Huang, Maryna Baydyuk
Filed: 2 Oct 19
Utility
mutw2muilqed7ns92rky83p5nquwum561euqwylfcco2
9 Dec 21
A triage system that determines whether a user is likely to have contracted a disease based on sensor data received from a user device (e.g., a smartphone or activity tracker).
Howard Federoff, Ophir Frieder
Filed: 19 Aug 21
Utility
of2xr0cjq1hstde9yt29 f9fk091df1nnvee65
2 Dec 21
Provided herein are compositions and methods for treating or preventing a neurodegenerative disease, a myodegenerative disease, a prion disease or a lysosomal storage disease in a subject.
Christian WOLF, Balaraman KALUVU, Charbel MOUSSA
Filed: 20 Nov 19
Utility
dwpzd45hpd9nkoso5t2ucclp
18 Nov 21
Embodiments may provide a cache for query results that can adapt the cache-space utilization to the popularity of the various topics represented in the query stream.
Ophir Frieder, Ida Mele, Raffaele Perego, Nicola Tonellotto
Filed: 21 Jul 21
Utility
xj4 nz8ladv7xp5zh32dnyo38vs8ut
4 Nov 21
A triage system that determines whether a user is likely to have contracted a disease based on sensor data received from a user device (e.g., a smartphone or activity tracker).
Howard Federoff, Ophir Frieder
Filed: 18 Aug 20
Utility
jknwzzys6n8shvo5alp0l3lhgi i4k1t9adseiscim
30 Sep 21
The present invention relates to anti-matriptase antibodies and immunoconjugates of anti-matriptase antibodies with cytotoxic agents and the use thereof for killing or inhibiting the growth of matriptase-expressing cancer cells, such as those of multiple myeloma and breast cancers.
Siang-Yo Lin, Joseph R. Bertino, Chen-Yong Lin, Zoltan Szekely
Filed: 12 Mar 21
Utility
9vgsskfyhzrzsvqrudd94bcp6wpo
16 Sep 21
The present invention relates to methods of determining if a subject has an increased risk of suffering from memory impairment.
Howard J. Federoff, Massimo S. Fiandaca, Amrita K. Cheema, Mark E. Mapstone
Filed: 25 Jan 21
Utility
15wpyke2ufcvtjiheim4el3jondve36 1pir
19 Aug 21
Embodiments of the present systems and methods may provide techniques for synthesizing speech in any voice in any language in any accent.
Joe GARMAN, Ophir FRIEDER
Filed: 14 Jun 19
Utility
9yh1kc4ety8ma8gfdts6hcmsosv 4bmi2hmaziotj2lc18sxeog
12 Aug 21
Provided herein is a method of treating medulloblastoma or glioblastoma in a subject by administering to the subject a PI3K activator (e.g., thymosin β-4 or a derivative thereof) and one or more chemotherapeutic agents and/or radiation.
Christopher Albanese, Aisha Naeem
Filed: 12 Mar 19
Utility
qr1t94yzm05ym4yf5lpdv2w95 wvc1fvol2iu
5 Aug 21
Provided are batteries and fuel cells incorporating a stripline detector for use in nuclear magnetic resonance (NMR).
YuYe J. TONG, Eric G. SORTE
Filed: 11 Jan 21
Utility
n2s0rni7p3ltu209wkzih74g577adm94z4kdqpj1xsthg96eqnyat8q7xs
29 Jul 21
A hypotheses generation and event recognition system that enables event recognition by analyzing documents to construct one or more qualitative metrics (e.g., frequency of keywords, changes in sentiment, occurrence of ontological terms, evolution of topics, etc.), establishing a baseline for the qualitative metric(s), and outputting changes to that baseline for display.
David M. Hartley, Nili S. Yossinger, Ophir Frieder
Filed: 31 May 19
Utility
tgaaira839k260g2a fn4duu4u1c8i34z8bdi7ax4ups4qpjof6y
22 Jul 21
Methods of transplanting target cells into a subject in need thereof.
Wanxing Cui
Filed: 2 Aug 19
Utility
smn0sniu9t98jp6f6gh0gg8e894smj5p5pg9b78e0v0hqw9bqehcxohuc8n4
8 Jul 21
The present invention is in the field of drug delivery, and specifically, cationic liposome-based drug delivery.
Esther H. CHANG, SangSoo KIM, Antonina RAIT
Filed: 5 Feb 21
Utility
ew26znr9o276rhbj9wzri59xc
17 Jun 21
The present invention relates to matriptase antibodies and immunoconjugates of matriptase antibodies with cytotoxic agents and the use thereof for killing or inhibiting the growth of matriptase-expressing cancer cells, such as those of multiple myeloma and breast cancers.
Siang-Yo Lin, Joseph R. Bertino, Chen-Yong Lin
Filed: 24 Feb 21